# BriaCell Therapeutics Corp.: Form 6-K, filed Sep 22, 2021

- Company: [BriaCell Therapeutics Corp.](/companies/bctx.md) (CIK 1610820)
- Form: 6-K
- Filed: 2021-09-22
- Accepted by EDGAR: Sep 22, 2021, 16:05 ET
- Period: 2021-09-22
- Accession: 0001493152-21-023360
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1610820/000149315221023360/form6-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1610820/000149315221023360/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1610820/000149315221023360/form6-k.htm

Filed Sep 22, 2021.
Source: SEC EDGAR, the filing index for accession 0001493152-21-023360. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
